Timeline of Schistosomiasis Control Initiative
This is a timeline of Schistosomiasis Control Initiative.
|Time period||Development summary||More details|
|Year||Month and date||Event type||Details||Location|
|2002||SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation, to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.|
|2002||SCI begins program in Uganda, the first operating country.||Uganda|
|2003||October||SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.|
|2003||SCI begins program in Zambia, Zanzibar, and Niger.||Zambia, Zanzibar, Niger|
|2006||Funding||SCI receives large grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and soil-transmitted helminths.|
|2007||Funding||SCI receives a grant to expand its work to Rwanda and Burundi.|
|2007||SCI program starts in Burundi.||Burundi|
|2010||SCI begins working in Côte d'Ivoire.||Côte d'Ivoire|
|2010||SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.|
|2010||October||Funding||SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.|
|2010||The World Health Organization reports that schistosomiasis mortality could be as high as 280,000 per year in Africa alone.|
|2011||Expansion||SCI begins program in Liberia, Malawi, and Mozambique.||Liberia, Malawi, Mozanbique|
|2012||Expansion||SCI program starts in Côte d'Ivoire, two years later due to political turmoil.||Côte d'Ivoire|
|2012||Expansion||SCI begins conversations with the Government of Ethiopia about starting a national schistosomiasis treatment program.||Ethiopia|
|2012||Coverage||SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.|
|2013||Expansion||SCI begins first round of treatment in Ethiopia and Mauritania.||Ethiopia, Mauritania|
|2013||A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in sub-Saharan Africa and only 12.7% receiving preventive chemotherapy.|
|2013 – 2014||Between November 2013 and April 2014||SCI funds mapping in Ethiopia.||Ethiopia|
|2014||Expansion||SCI begins program in the Democratic Republic of the Congo and Madagascar.||Democratic Republic of the Congo, Madagascar|
|2014||SCI begins working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program.|
|2014||Funding||The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.|
|2014||Coverage||ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.|
|2014 – 2015||Coverage||SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.||Côte d'Ivoire|
|2015||Coverage||ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.|
|2015||Schistosomiasis is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.|
|2015 – 2016||SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.|
|2015 – 2016||Between April 2015 and March 2016||SCI spends around US$2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia during the period.|
|2015 – 2016||Between April 2015 and March 2016||SCI reports having delivered 890,000 treatments in Uganda, out of 1.2 million planned treatments.|
|2011||Expansion||SCI begins program in Nigeria.||Nigeria|
|2016||January||Funding||Private foundation Good Ventures awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015.|
|2016||August||GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).|
|2017||January||Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.|
|2017||GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.|
|2018||"In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."|
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by User:Sebastian.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
What the timeline is still missing
Timeline update strategy
- "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019.
- "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019.
- Adenowoa, Abiola Fatimah; Oyinloyea, Babatunji Emmanuel; Ogunyinkaa, Bolajoko Idiat; Kappo, Abidemi Paul. "Impact of human schistosomiasis in sub-Saharan Africa". Brazilian Journal of Infectious Diseases. doi:10.1016/j.bjid.2014.11.004.
- "OUR REACH". schistosomiasiscontrolinitiative.org. Retrieved 12 March 2019.
- "Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016". givewell.org. Retrieved 12 March 2019.
- "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019.
- Savioli, Lorenzo; Albonico, Marco; Colley, Daniel G.; Correa-Oliveira, Rodrigo; Fenwick, Alan; Green, Will; Kabatereine, Narcis; Kabore, Achille; Katz, Naftale; Klohe, Katharina; LoVerde, Philip T.; Rollinson, David; Russell Stothard, J.; Tchuem Tchuenté, Louis-Albert; Waltz, Johannes; Zhou, Xiao-Nong. "Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty". PMC . PMID 28330495. doi:10.1186/s40249-017-0280-8.
- "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019.
- "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019.
- "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019.
- "HOW YOUR MONEY IS SPENT". schistosomiasiscontrolinitiative.org. Retrieved 15 March 2019.